Order Article Reprints

Hsu H-C, You J-F, Chen S-J, Chen H-C, Yeh C-Y, Tsai W-S, Hung H-Y, Yang T-S, Lapke N, Tan KT. TP53 DNA Binding Domain Mutations Predict Progression-Free Survival of Bevacizumab Therapy in Metastatic Colorectal Cancer. Cancers. 2019; 11(8):1079. https://doi.org/10.3390/cancers11081079

Hsu, Hung-Chih, Jeng-Fu You, Shu-Jen Chen, Hua-Chien Chen, Chien-Yuh Yeh, Wen-Sy Tsai, Hsin-Yuan Hung, Tsai-Sheng Yang, Nina Lapke, and Kien Thiam Tan. 2019. "TP53 DNA Binding Domain Mutations Predict Progression-Free Survival of Bevacizumab Therapy in Metastatic Colorectal Cancer" Cancers 11, no. 8: 1079. https://doi.org/10.3390/cancers11081079

Hsu, H.-C., You, J.-F., Chen, S.-J., Chen, H.-C., Yeh, C.-Y., Tsai, W.-S., Hung, H.-Y., Yang, T.-S., Lapke, N., & Tan, K. T. (2019). TP53 DNA Binding Domain Mutations Predict Progression-Free Survival of Bevacizumab Therapy in Metastatic Colorectal Cancer. Cancers, 11(8), 1079. https://doi.org/10.3390/cancers11081079